# US 2010/0146671 A1 · Targeting vector

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0146671 A1
- Document ID: US20100146671A1
- Status: Published application
- Kind: A1
- Application number: 11/993,410
- Filed: 2006-06-23
- Published: 2010-06-10
- Earliest claimed: 2005-06-24
- Assignees: Australian Centre for Plant Functional Genomics Pty Ltd
- Inventors: Olivier Cotsaftis; Mark Alfred Tester
- Web page: https://patentgrep.com/patent/US20100146671A1

## CPC

- C12N 15/8213: {Targeted insertion of genes into the plant genome by homologous recombination}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates generally to nucleic acid constructs, which are useful for inserting a nucleotide sequence of interest into a target nucleic acid molecule via homologous recombination. The present invention also relates to methods for producing such constructs.

## Claims

### Claim at position 1

1-45. (canceled)

### Claim 46

A nucleic acid construct for inserting a nucleotide sequence of interest into a target nucleic acid molecule via homologous recombination, the nucleic acid construct comprising genetic element (I) as shown below:
[NSM1-RSα-5′HR-RSβ-nsoi-RSγ-3′HR-RSδ-NSM2] (I)
wherein:
NSM1 comprises a nucleotide sequence encoding a negative selectable marker, or optionally may be absent if a nucleotide sequence encoding a negative selectable marker is present at NSM2;
RSα comprises a nucleotide sequence defining a first recombination site;
5′HR comprises a nucleotide sequence which is homologous to a nucleotide sequence 5′ to, and/or inclusive of, a nucleotide sequence in the target nucleic acid molecule;
RSβ comprises a nucleotide sequence defining a second recombination site;
nsoi comprises a nucleotide sequence of interest to be inserted into the target nucleic acid molecule;
RSγ comprises a nucleotide sequence defining a third recombination site;
3′HR comprises a nucleotide sequence which is homologous to a nucleotide sequence 3′ to, and/or inclusive of, a nucleotide sequence in the target nucleic acid molecule;
RSδ comprises a nucleotide sequence defining a fourth recombination site;
NSM2 comprises a nucleotide sequence encoding a negative selectable marker, or optionally may be absent if a nucleotide sequence encoding a negative selectable marker is present at NSM1;
wherein homologous recombination between the regions of homology, 5′HR and/or 3′HR, and homologous nucleotide sequences in the target nucleic acid molecule results in insertion of the portion of genetic element (I) which is bounded by, and optionally inclusive of, 5′HR and 3′HR, into the target nucleic acid molecule.

### Claim 47 (depends on 46)

The targeting construct of claim 46 wherein nsoi comprises a nucleotide sequence encoding a positive selectable marker.

### Claim 48 (depends on 46, 47)

The targeting construct of claim 46 or 47 wherein each of RSα, RSβ, RSγ and RSδ comprise lambda phage att sites.

### Claim 49 (depends on 46)

The genetic construct of claim 46 wherein the genetic construct further comprises T-DNA border sequences flanking genetic element (I).

### Claim 50 (depends on 46)

A method for inserting a nucleotide sequence of interest into a nucleic acid molecule in a cell via homologous recombination, the method comprising administering to the cell the nucleic acid construct of claim 46; and selecting transformants which comprise the inserted nucleotide sequence of interest on the basis of the presence and/or expression of the nucleotide sequence of interest in the cell, and/or the absence of expression of one or both of the negative selectable markers NSM1 and NSM2 in the cell.

### Claim 51 (depends on 50)

The method of claim 50 wherein the cell is a plant cell.

### Claim 52 (depends on 46)

A genetically modified cell comprising either the construct of claim 46 or a genomically integrated form of said construct.

### Claim 53 (depends on 52)

The genetically modified cell of claim 52 wherein the cell is a plant cell.

### Claim 54 (depends on 50, 52)

The genetically modified cell of claim 52 wherein the cell is produced according to the method of claim 50.

### Claim 55 (depends on 52)

A multicellular structure comprising one or more of the genetically modified cells of claim 52.

### Claim 56 (depends on 55)

The multicellular structure of claim 55 wherein the multicellular structure is a plant.

### Claim 57 (depends on 46)

A method for producing a genetic construct comprising genetic element (I) as defined in claim 46, the method comprising:
providing one or more nucleic acid molecules which together comprise genetic elements (II), (III), (IV) and (V) as shown below:
[NSM1-RSa-RSd-NSM2] (II)
[RSa′-5′RH-RSb] (III)
[RSb′-nsoi-RSc′] (IV)
[RSc-3′RH-RSd′] (V)
wherein:
NSM1 comprises a nucleotide sequence encoding a negative selectable marker, or optionally may be absent if a nucleotide sequence encoding a negative selectable marker is present at NSM2;
NSM2 comprises a nucleotide sequence encoding a negative selectable marker, or optionally may be absent if a nucleotide sequence encoding a negative selectable marker is present at NSM1;
5′HR comprises a nucleotide sequence which is homologous to a nucleotide sequence 5′ to, and/or inclusive of, a nucleotide sequence in the target nucleic acid molecule;
nsoi comprises a nucleotide sequence of interest to be inserted into the target nucleic acid molecule;
3′HR comprises a nucleotide sequence which is homologous to a nucleotide sequence 3′ to, and/or inclusive of, a nucleotide sequence in the target nucleic acid molecule; and
RSa is a nucleotide sequence defining a recombination site which can recombine with RSa′ when acted on by a recombinase; RSb is a nucleotide sequence defining a recombination site which can recombine with RSb′ when acted on by a recombinase, RSc is a nucleotide sequence defining a recombination site which can recombine with RSc′ when acted on by a recombinase and RSd is a nucleotide sequence defining a recombination site which can recombine with RSd′ when acted on by a recombinase; and
(ii) administering one or more recombinases to the one or more nucleic acid molecules comprising genetic elements (II), (III), (IV) and (V) such that RSa and RSa′ recombine to yield the recombination site RSα, RSb and RSb′ recombine to yield the recombination site RSβ, RSc and RSc′ recombine to yield the recombination site RSγ, and RSd and RSd′ recombine to yield the recombination site RSδ, thereby generating a nucleic acid construct comprising genetic element (I).

### Claim 58 (depends on 57)

The method of claim 57 wherein each of genetic elements (II), (III), (IV) and (V) are provided on separate nucleic acid molecules or vectors.

### Claim 59 (depends on 57)

The method of claim 57 wherein the nsoi comprises a nucleotide sequence encoding a positive selectable marker.

### Claim 60 (depends on 57)

The method of claim 57, wherein RSa, RSa′, RSb, RSb′, RSc, RSc′, RSd and RSd′ comprise lambda phage att sites.

### Claim 61 (depends on 57)

A nucleic acid construct comprising genetic element (II) as defined in claim 57.

### Claim 62 (depends on 61)

The nucleic acid construct of claim 61 wherein RSa and RSd comprise lambda phage att sites.

### Claim 63 (depends on 57, 61)

A kit for performing the method of claim 57, the kit comprising the genetic construct of claim 61 together with instructions for performing the method of claim 57.
